Work

Stimulation of the HER-kinase axis promotes resistance to the Raf-kinase activity of sorafenib, which can be reversed by the addition of MEK inhibitor U0126

Year: 2007

Type: article

Source: Cancer Research

Authors: Anjali Jain, Michael Hedvat, Joanna Schmidt, David B. Agus

Institution: Cedars-Sinai Medical Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W997745954

FWCI:

Cites:

Cited by:

Related to: 10